8MM,COBRA GRASPER,IS4000 REF 471190 Recall
8MM,COBRA GRASPER,IS4000 REF 471190
FDA recall Class II
Ongoing
FDA lists this Class II recall for 8MM,COBRA GRASPER,IS4000 REF 471190. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0877-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Dec 19, 2024
- FDA report date
- Jan 22, 2025
- Quantity in commerce
- 2,472
- Distribution
- See key details
- FDA cause
- Process change control
What is being recalled?
8MM,COBRA GRASPER,IS4000 REF 471190
Affected model & UDI checker
Search the exact identifiers published for Z-0877-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 471190 | 8MM,COBRA GRASPER,IS4000 REF 471190 | Check source notice | Not specified |
| Not specified | 8MM,COBRA GRASPER,IS4000 REF 471190 | Check source notice | 00886874121481 |
FDA code information
Model Number: 471190 Part Number: 471190-04 UDI-DI code: 00886874121481 Batch Numbers: K10230226 K10230405 K10230413 K10230420 K10231005 K10231019 K10231130 K10240104 K10240111 K10240118 K10240327 K10240418 K10240502 K10240606 K10240725
Why was this product recalled?
Due to increased complaints regarding frayed or broken grip cables on reusable instruments with jaws.
What actions did Intuitive Surgical, Inc. take?
On 12/19/2024, the firm send via email an "Urgent: Medical Device Correction" Letter informing customer that Intuitive Surgical has become aware of an increase in complaints regarding frayed or broken cables on some da Vinci X and Xi reusable instruments. Customer are instructed to: 1. Customers can continue using the products in accordance with the user manual. 2. As a reminder, when using da Vinci X and Xi reusable instruments, follow the Inspection Before Use and Warnings listed in the manual provided with your system to inspect for any broken cables. Refer to Figures C and D for examples. In addition, please refer to Appendix B for additional images for detection of grip cable failures. 3. If you observe any failed (frayed or broken) grip cables prior to use, during procedure, or during reprocessing, please stop use of instrument, remove from use and inform Intuitive via the standard complaint process. 4. Inform Intuitive of any Adverse Events*/Serious Incidents** or quality problems concerning the use of the subject device via the standard complaint process. For Question and assistance - " North and South America: (800) 876-1310, Option 3 (4 am to 5 pm PST) or mail: customerservice@intusurg.com. " Europe, Middle East, Asia and Africa: +800 0821 2020 or +41 21 821 2020 (8 am to 6 pm CET) or eucs@intusurg.com " South Korea: 02-3271-3200 (9 am to 6 pm KSTJ) or support.korea@intusurg.com " Japan: 0120-56-5635 or 03-5575-1362 (9 am to 6 pm JST) or csjapan@intusurg.com " India: +1-800-103-6952 (9 am to 6 pm IT) " Taiwan: +0800-86-8181 (9 am to 6 pm CT)
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0877-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology